This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Society Of Hematology Announces First Recipients Of Bridge Grants To Support Critical Blood Disease Research During Current Period Of Funding Restrictions

Award announcement accompanies Society's lead support of today's "Rally for Medical Research"

WASHINGTON, April 8, 2013 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatment of blood disorders, today announced the first recipients of the ASH Bridge Grants, a new award program designed to help hematologists continue their critical blood disease research amid severe funding reductions for the National Institutes of Health (NIH). The announcement coincides with the Society's participation as a Platinum Supporter in the " Rally for Medical Research," held today in Washington, which will unite millions of Americans across the country to call on our nation's policymakers to make medical research a national priority.

"We know that continued, devastating cuts to NIH funding pose a real threat to the future of medicine and will likely cause many talented investigators to abandon biomedical research as a career path," said ASH President Janis L. Abkowitz, MD, of the University of Washington in Seattle.

To help address this crisis, ASH committed $9 million in July 2012 to create the grant program intended to provide its member researchers with critical interim support to sustain their hematology research during a time of sustained NIH budget cuts, including a $1.6 billion cut this year plus additional cuts to come over the next several years as a result of sequestration.

"While the establishment of this program represents an unprecedented financial commitment on the part of ASH, we recognize that it provides nowhere near what is needed to replace the NIH funding that has been cut for hematology research," said Dr. Abkowitz. "What we really need is for Congress to understand that medical research is a national priority, which is why it was so important for ASH to support today's rally at the highest level."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs